Tamm I - Search Results

1

HBXIP functions as a cofactor of survivin in apoptosis suppression.

Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC. Marusawa H, et al. Among authors: tamm i. EMBO J. 2003 Jun 2;22(11):2729-40. doi: 10.1093/emboj/cdg263. EMBO J. 2003. PMID: 12773388 Free PMC article.

2

Peptides targeting caspase inhibitors.

Tamm I, Trepel M, Cardó-Vila M, Sun Y, Welsh K, Cabezas E, Swatterthwait A, Arap W, Reed JC, Pasqualini R. Tamm I, et al. J Biol Chem. 2003 Apr 18;278(16):14401-5. doi: 10.1074/jbc.M210133200. Epub 2003 Jan 21. J Biol Chem. 2003. PMID: 12538646 Free article.

3

A single BIR domain of XIAP sufficient for inhibiting caspases.

Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa-Munt N, Salvesen GS, Reed JC. Takahashi R, et al. Among authors: tamm i. J Biol Chem. 1998 Apr 3;273(14):7787-90. doi: 10.1074/jbc.273.14.7787. J Biol Chem. 1998. PMID: 9525868 Free article.

4

IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.

Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. Tamm I, et al. Cancer Res. 1998 Dec 1;58(23):5315-20. Cancer Res. 1998. PMID: 9850056

5

Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC. Tamm I, et al. Clin Cancer Res. 2000 May;6(5):1796-803. Clin Cancer Res. 2000. PMID: 10815900

6

High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.

Tamm I, Richter S, Oltersdorf D, Creutzig U, Harbott J, Scholz F, Karawajew L, Ludwig WD, Wuchter C. Tamm I, et al. Clin Cancer Res. 2004 Jun 1;10(11):3737-44. doi: 10.1158/1078-0432.CCR-03-0642. Clin Cancer Res. 2004. PMID: 15173080

7

In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.

Wagner M, Schmelz K, Wuchter C, Ludwig WD, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2006 Sep 15;119(6):1291-7. doi: 10.1002/ijc.21995. Int J Cancer. 2006. PMID: 16619249

8

Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factor.

Wagner M, Schmelz K, Dörken B, Tamm I. Wagner M, et al. Among authors: tamm i. Int J Cancer. 2008 Mar 15;122(6):1278-87. doi: 10.1002/ijc.23183. Int J Cancer. 2008. PMID: 18027854

9

5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.

Schmelz K, Wagner M, Dörken B, Tamm I. Schmelz K, et al. Among authors: tamm i. Int J Cancer. 2005 May 1;114(5):683-95. doi: 10.1002/ijc.20797. Int J Cancer. 2005. PMID: 15609309

10

XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.

Tamm I, Richter S, Scholz F, Schmelz K, Oltersdorf D, Karawajew L, Schoch C, Haferlach T, Ludwig WD, Wuchter C. Tamm I, et al. Hematol J. 2004;5(6):489-95. doi: 10.1038/sj.thj.6200549. Hematol J. 2004. PMID: 15570290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters